Embed Size (px)
Citation preview
1
Audrey’s Life Science Meeting Picks for April 17, 2016 – August 2016
Complimentary Service of AudreysNetwork.com
April 17, 2016
*****************************************************************
Bio2Device Group, Tuesday Morning, April 19, 2016
Topic: “Women’s Sexual Wellness in 2016: Can Great Medical Products Change the
Conversation?”
Speaker: Holly Rockweiler, CEO & Co-Founder, Madorra
Date and Time: Tuesday, April 4, 2016, 8:30am
Location: Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
No cost and no registration for morning meetings.
Topic Description
With all the press around the Pink Pill, Osphena, and other "female viagras," women's
sexual wellness is a hot topic. What do all these products do? What does it all mean, and
why now? Join us for a presentation and discussion on the current state of women's sexual
wellness in the healthcare industry and add your thoughts to this dynamic conversation.
Speaker Bio
Holly Rockweiler is Co-Founder and CEO of Madorra, a women's health company dedicated
to changing the treatment paradigm for vaginal dryness. She co-founded Madorra 2 years
ago as a spin out of the Stanford Biodesign Fellowship. Prior to Biodesign, she worked as a
Senior Research Scientist in the Cardiac Rhythm Management division of Boston Scientific.
At Boston, she co-developed a new sensing algorithm for cardiac resynchronization therapy
that enables more efficient care for patients living with heart failure. Her work has led to
thirteen pending and issued patents assigned to Boston Scientific. Holly holds a Masters and
a Bachelor degree in Biomedical Engineering from Washington University in St. Louis.
********************************************************
JLABS, Wednesday, April 20, 2016
Event: WORKSHOP 2 | IPO Readiness Bootcamp | April 20
Date and Time: Wednesday, April 20, 2016, 8:00 am
Agenda:
Event starts at Genentech Hall / Byers Auditorium
8:00 AM | Registration, Networking and Breakfast
9:00 AM | Welcome and Event introduction
Move to Mission Hall / Assigned rooms
9:40 AM | Get to your breakouts
9:50 AM | Breakout 1
10:50 AM | Get to your breakouts
11:00 AM | Breakout 2
12:00 PM | Lunch
12:50 PM | Breakout 3
1:50 PM | Coffee Break
2:00 PM | Get to your breakouts
2:10 PM Breakout 4
3:20 PM | Program Close
2
Facilitators:
Investment Banker:
Jennifer Jarrett | Managing Director , Citigroup's Health Care Investment Banking
Group
Attorneys:
Michael Tenta | Partner, Cooley LLP
Carlton Fleming | Associate, Cooley LLP
D&O Insurance:
Steve Sawyer | Partner & Executive Vice President, Woodruff-Sawyer &Co
Priya Cherian Huskins | Partner & Senior Vice President, Woodruff-Sawyer &Co
Auditors:
Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
Jason Richter | National Federal Tax Services Transaction & Integration
Services, Deloitte Tax LLP
David Lyness | Director, Deloitte Tax Services
Locations:
UCSF Genentech Hall / Byers Auditorium: 600 16th St, San Francisco, CA
UCSF Mission Hall: 1599 4th St, San Francisco, CA
Day 2 Fees:
$65 | General Public (limited availability)
No Onsite Registration!
Register at http://www.eventbrite.com/e/how-to-ipo-series-tickets-
20106147027?aff=blast#Day1
Event Description
Are you on IPO watch? Whether IPO starts are up or down, and they will be up and
down, the most important time for your company to be IPO ready is now. Expertise
learned by being IPO ready benefits your firm regardless of your final go/ no-go IPO
decision. Join us for the ultimate IPO crash course to learn directly from the pros.
There are many stakeholders to manage when you prepare your company for an IPO
exit, including your investors, bankers, attorneys, auditors and insurance advisors.
We invited them all to share their insights, real stories, case studies and to answer
your pressing questions. Don't miss this opportunity to enhance your knowledge and
understanding of the step by step IPO process during our day-long program.
The Bootcamp features small group sessions with investment bankers, attorneys,
insurance and auditors/tax professionals to provide focus on individual needs.
Through direct interactions with these professionals, you will become confident in
building your IPO readiness plan as well as learn from group member experiences
and questions.
Key questions about preparing for the IPO process through IPO pricing and closing
will be answered including:
When and how to start IPO readiness process?
Are your investors and internal processes ready for the IPO?
Who from your company will be involved in the process and how much time
does it take?
How to manage your relationships with auditors during the process and what
to expect and when?
When and how to engage and choose your bankers?
What to expect from banker's due diligence?
IPO process detailed steps and timing
3
Registration statement drafting - who is involved, how long does it take, what
it includes and who will help with draft creation?
SEC review process of the registration statement
Roadshow - how to be best prepared for it?
IPO pricing and IPO closing - who is involved and what are their roles?
What do you need to know about D&O insurance? - Who sues you, and for
what, as a public company?
What are three pillars of protection to mitigate D&O risk?
What is the timeline for D&O Insurance for an IPO, including what are private
companies' transition issues?
Also, bring your own questions to receive direct, practical responses from our group
of professional advisors. The more you know, the better prepared your internal
resources and processes are to meet IPO challenges. After this program, you will be
equipped to build stronger and more efficient relationships with all stakeholders,
improve your IPO plan and more efficiently manage your IPO costs.
2016 Global sciences outlook: Moving forward with cautious optimism
Speakers' Biographies
Jennifer Jarrett | Managing Director , Citigroup's Health Care Investment Banking
Group
Jennifer is a Managing Director in Citigroup's Health Care Investment Banking Group.
At Citi, Jennifer focuses on raising capital for and advising companies in the
biotechnology sector. Prior to joining Citi in 2010, Jennifer was the Head of U.S.
Biotechnology at Credit Suisse where she spent 12 years. Jennifer started her career
working at Kidder Peabody and Merrill Lynch and has now spent almost 20 years in
investment banking, 16 of these years focused on the biotechnology sector. Since
Jennifer joined Citi in 2010, she has raised over $5B of capital for biotechnology
companies including several in the oncology sector. These companies include Ambit
Bio, Amgen, Epizyme, Five Prime, Halozyme, Jazz Pharmaceuticals, Medivation,
Mirati, Onconova, Puma Biotechnology and Tesaro. Jennifer has advised on a number
of M&A transactions over the course of her career. Jennifer is on the board of the
Clearity Foundation, a non-profit organization focused on improving treatment
options for ovarian cancer, and has organized several events to raise funds for
Clearity. Jennifer was elected to San Francisco Business Times Most Influential
Women in Business in 2014. Jennifer graduated from Dartmouth College, cum laude,
with a BA in Economics and received her MBA from the Stanford Graduate School of
Business. Jennifer is a native of Houston, Texas but has been in the Bay Area since
1996. In her free time, Jennifer enjoys golfing, skiing and running.
Michael Tenta | Partner, Cooley LLP
Michael E. Tenta is a partner in the Cooley Business department. He joined the Firm
in 2000 and is resident in the Palo Alto office. Mr. Tenta practices corporate and
securities law, representing public and private companies, investors and investment
banks in a variety of matters, including securities offerings, mergers and
acquisitions, and general corporate and commercial law. Prior to joining Cooley, Mr.
Tenta was an associate at the law firm of Lawson Lundell in Vancouver, Canada,
where he advised both public and private companies in the technology,
manufacturing and resource sectors. Mr. Tenta graduated from the University of
Victoria Faculty of Law in 1997. During his legal studies, he spent a term working at
the Intellectual Property Policy Directorate of the Government of Canada and at the
4
University of the South Pacific Department of Law. Mr. Tenta graduated from Simon
Fraser University with a BS (Biology) in 1993. Mr. Tenta is a member of the State Bar
of California, the American Bar Association and the Law Society of British Columbia.
Mr. Tenta is not admitted to practice in Washington state.
Carlton Fleming | Associate, Cooley LLP
Carlton Fleming is an associate in Cooley's Business department and a member of the
Public Companies, Capital Markets and Emerging Companies practice groups. He
joined the Firm in 2012 and is resident in the Palo Alto office. Carlton practices
general corporate and securities law, representing both public and private companies
in a wide range of matters, including formation and financing activities, SEC
reporting and compliance, corporate governance and mergers and acquisitions. He
also represents investment banks and venture capital firms in public offerings and
private placements of equity and debt securities. Since 2012, Carlton has been
involved in over 25 IPOs and other public offerings, raising over $3 billion. Carlton
received a JD and an LLM in International and Comparative Law in 2007 from Duke
University School of Law. He received a BA in German and History in 2004 from Duke
University. Mr. Fleming is a member of the State Bar of California and the State Bar
of North Carolina.
Steve Sawyer | Partner & Executive Vice President, Woodruff-Sawyer &Co
A trusted advisor to Silicon Valley companies and beyond, Steve's creativity and
passion for solving clients' most complex risk challenges has led him to become an
industry innovator. Steve has been partnering with technology and life sciences
clients since joining the firm in 1981. He launched its Life Sciences Practice in 1991—
today one of the nation's largest. Under Steve's leadership, Woodruff-Sawyer as the
Biotechnology Industry Organization's (BIO's) as its West Coast risk management
partner. Steve works with organizations from new venture formation through IPO,
commercialization and international expansion. In addition to P&C, he has extensive
experience addressing D&O liability needs of public company clients. Steve also
founded Woodruff-Sawyer's CleanTech Practice in 2008. He worked with global
insurers to create innovative Performance Warranty programs for solar and other
clean tech projects, providing customized financial backstops to facilitate
"bankability" for securing financing for various projects. Steve is on Woodruff-
Sawyer's Board of Directors and has served on the board for BayBio, the
biotechnology trade organization for Northern California. He is active in various non-
profits and missions committed to pressing needs in our community and around the
world. Steve has a bachelor's degree from Stanford University and an MBA from
Northwestern University's Kellogg Graduate School of Management. He is a
designated Chartered Property and Casualty Underwriter (CPCU).
Priya Cherian Huskins, Esq. | Partner & Senior Vice President, Woodruff-Sawyer &Co
Priya Cherian Huskins is a recognized expert in D&O liability risk and its mitigation.
In addition to consulting on D&O insurance matters, she counsels clients on corporate
governance matters, including ways to reduce their exposure to shareholder lawsuits
and regulatory investigations. Priya is a frequent speaker on D&O issues and a
regular guest lecturer at Stanford's Directors' College, among others. She is also the
author of the D&O Notebook, a blog that monitors, curates and summarizes issues as
they arise in the areas of D&O liability, insurance and corporate governance. Priya
serves on the board of directors of Realty Income Corporation (NYSE: O) as well as
the Advisory Board for the Stanford University Rock Center for Corporate
Governance. Priya is also on the board of the of the Silicon Valley Directors'
Exchange (SVDX). Priya was listed as one of the "Most Influential Women in Bay Area
5
Business" by the San Francisco Business Times in 2012. She was a judge for the
prestigious Ernst & Young Entrepreneur of the Year award in Northern California from
2009-2011. Priya was named one of the "Top 100 Women of Influence in the Silicon
Valley" in 2009 by the San Jose/Silicon Valley Business Journal. Prior to joining
Woodruff-Sawyer, Priya practiced corporate and securities law at Wilson Sonsini
Goodrich & Rosati. Priya has worked with both public and private technology
companies through all stages of their development. Priya was awarded her juris
doctorate with honors from the Law School at the University of Chicago. She earned
her undergraduate degree with high honors from Harvard University. Priya is a
member of the California Bar.
Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
Angela has 20 years of experience serving both public and private companies with a
focus on the life sciences industry. She works with companies in all stages of growth,
from start-ups to SEC registrants. Her technical background includes complex
accounting issues such as revenue recognition, equity, derivatives, stock-based
compensation, and acquisitions. Angela has been involved in financing and M&A
transactions, including initial public offerings, offerings in leveraged buyouts, and
several secondary shares offerings. She has extensive international experience and is
a certified public accountant in the United States and the United Kingdom. Angela
also served as a CFO before returning to public accounting in 2003.
Jason Richter | National Federal Tax Services Transaction & Integration Services,
Deloitte Tax LLP
Jason is a Senior Manager with National Federal Tax Services (Transaction &
Integration Services), Deloitte Tax LLP, and has over 14 years of professional
experience specializing in corporate tax matters including merger and acquisition
related due diligence, tax structuring, and tax modeling. Jason is primarily involved
in providing Section 382 and NOL consulting services including the day to day
management of the preparation of full Section 382 ownership change studies and the
computation of the related annual limitations. Jason is also responsible for the
preparation and review of quarterly Section 382 update analyses and the review of
studies in support of tax return preparation and financial statement reporting and
disclosure. Jason is frequently involved in providing Section 382 services as part of
due diligence for merger and acquisition transactions as well as NOL planning and
structuring. He serves a variety of public and private company clients. Jason has
been providing Section 382 services for over eleven years, authored several articles
in this area, and has appeared as a guest lecturer on the topic.
David Lyness | Director, Deloitte Tax Services
David leads Deloitte's Silicon Valley R&D tax credit practice. Over the past 20 years,
David has specialized in serving life science and other technology companies. Primary
focus areas include developing R&D tax credit claims and representing clients before
the IRS and state tax authorities. David is a member of the New York Bar, and has
degrees in accounting and law, including an LL.M (Tax) from New York University
School of Law.
**************************************************************
Palo Alto AWIS, Wednesday Evening, April 20, 2016
Topic: “Compassion and Mindfulness in the Workplace:
How a Compassionate Attitude Strengthens Leadership Skills and Relationships”
Speaker: Dawa Gail Lorien, PhD
Date and Time: Wednesday, April 20, 216, 7- 9 pm
6
7:00-7:30: Networking dinner
7:30-7:45: Announcements
7:45-9:00: Seminar
Location: PARC Auditorium, 3333 Coyote Hill Rd, Palo Alto, CA 94304
Palo Alto AWIS Members: FREE
Pre-registered Non-Members: $10
Fee at Door: $15
Register at http://www.brownpapertickets.com/event/2531766
Topic Description
Do you struggle with maintaining a work-life balance? Do you want to make room for
compassion in today's fast-paced world?
AWIS Palo Alto has invited Dawa Gail Lorien, PhD to inspire you and help you
cultivate compassion for yourselves and those around you - at home, at work, and in
every aspect of your lives.
After this workshop, you will:
• Appreciate how a compassionate attitude in the workplace can be a strength in
leadership and relationships
• Understand how to cultivate compassion in every aspect of your life
• Learn how to develop effective practices for work-life balance
Speaker Bio
Dawa has a Phd in Anthropology and has been a student of Buddhist Meditation and
Dzogchen for over 35 years. A Certified Instructor in Compassion Cultivation Training (CCT)
at the Center for Compassion and Altruism Research and Education (CCare), Stanford
University, Dawa's life’s objective is a seamless integration of present awareness,
mindfulness and compassion into daily life—balancing a contemplative retreat life with
family and work.
***********************************************************
EMBS, Wednesday Evening, April 20, 2016
Topic: “A History of Robotic Surgery, Controversy and Future Developments”
Speaker: Jonathan Sorger, Sr. Director of Medical Research, Intuitive Surgical, Inc.
Date and Time: Wednesday, April 20, 2016, 7:30 PM
Location: Room M-114, Stanford University Medical School
Optional dinner location: Stanford Hospital cafeteria, 6:15 PM (no host, no reservations)
Topic Description
Intuitive Surgical was founded about 3 miles from Stanford in 1995 and helped usher in an
era in which computer-assistance brought minimally invasive surgery to millions of patients.
Today, Intuitive is the global technology leader in minimally invasive robotic-assisted
surgery, is headquartered in Sunnyvale, and employs over 3000 people. The company
designs, engineers and manufactures the da Vinci® Surgical System, which enables
surgeons to operate through a few small incisions or the belly button from a nearby console.
The System features a 3D, fluorescence-capable vision system and tiny wristed instruments
with greater precision and dexterity than the human hand. Released in 2014, the da Vinci Xi
System is the latest iteration of the System, and over 3500 da Vinci's are used to perform
approximately 1800 surgeries per day around the world. During this presentation, Jonathan
7
Sorger will talk about the history of the company, some of the challenges it has faced and
how it views technology development.
Speaker Bio
Jonathan Sorger grew up in the South Bay, graduating from Leland High School in 1992. He
went on to study bioengineering at the University of California, San Diego and obtained his
PhD and MBA degrees from Johns Hopkins University while working at the National Heart
Lung and Blood Institute on cardiovascular MRI and stem cell biology. Jonathan returned to
the Bay Area in 2003, helping to develop the first-year PhD curriculum for the newly-formed
Bioengineering department at Stanford, where he taught until 2006. With his first child on
the way and a startup not progressing very quickly, Sorger moved a whopping 3 miles away
to work at Varian Medical Systems, where he helped manage Varian’s biology research as it
related to radiation oncology. In 2010 Jonathan started at Intuitive Surgical, where he
focused on bringing alternative imaging modalities into the surgical scene. Today he works
in research, helping to evaluate and adapt new technologies for use with robotic systems in
order to improve patient outcomes during surgical interventions. Jonathan enjoys running,
flying planes and being in the water.
*****************************************************
West Coast Chapter PDA, Thursday, April 21, 2016
Event: “Women in the Biopharmaceutical Industry:A Panel Discussion and Networking with
Company Leaders”
Date and Time: April 21 , 2016,6:00-9:30 PM
Agenda
6:00pm Registration and Networking
7:00pm Dinner
7:45pm Announcements
8:00pm Presentation and Discussion
9:30pm Closing
Location: Dominic's at Oyster Point | So. San Francisco, CA
Topic Description
Come hear the career stories, challenges and successes of our esteemed panelists as they
discuss their personal journeys into the biopharmaceutical industry. They'll discuss the
challenges women can expect to face upon entering the job market as well as share general
advice for women (and men) hoping to build their careers in the industry.
Registration
Pre-registration is $50 for PDA members and $60 for non-members (Credit/Cash/Check)
Additional $5 for Walk-in/At-Door registration.
There is a $15 discount for Government Employees and Students
PDA members: Please include your member ID number (after your name) in your
registration.
Use the following link to register.
If your device or email does not support registration/payment through the PayPal link, you
can submit registration requests via e-mail to [email protected] with "WCC PDA Dinner
RSVP" as the subject line. Indicated name and company affiliation for each registrant. If
you provide your information, a seat will be reserved for you.
Reserved seating is limited to the first 100 registrants! It is strongly encouraged that you
register in advance to ensure seating at this event, and to allow us to provide an accurate
head count for meals.
8
Speaker Bios
Melissa Morandi (Moderator) is currently the VP of Global Quality for Aegerion
Pharmaceuticals, and international company focused on the development and
commercialization of orphan drugs. Previously, she was VP of Quality at Acceleron Pharma,
and Vice President of Quality at Anesiva. Prior to joining Anesiva, Ms. Morandi held director
and managerial positions at Biogen, Genentech and Amgen. She holds a B.A. degree from
the University of California at Santa Barbara and a M.S. degree in Immunology from
California State University at Northridge.
Maura Lynch is the Director of business Development for Delta Project Management where
she oversees the business development and personnel management for the company. With
over 8 years of experience in the biotechnology and pharmaceutical industries, Ms. Lynch
has worked with many clients throughout the Bay Area including Genentech, Bayer,
Novartis, BioMarin and Boehringer-Ingelheim. She grew up in San Francisco, graduated
from the University of San Francisco and now calls Oakland home.
Sara Brien is currently Director of Technical Operations for Dynavax Technologies where she
is responsible for global project management and planning of CMC related product/process
development activities. Ms. Brien has 15 years of experience in pharmaceutical and
biotechnology manufacturing and supply chain operations. She has previously worked at
Grifols and Novartis where she held positions of increasing responsibility. Prior to joining
Novartis Ms. Brien worked at Enzo Life Sciences, Assay Designs and Sanofi Pasteur.
Elizabeth Leininger is a consultant for Regulatory Affairs and Quality with more than 18
years of diverse experience. Previously she was VP Regulatory Affairs, Quality Assurance
and Clinical Operations at StemCells and VP of Regulatory Affairs and Quality at BAS
Medical. Formerly a consultant with The Biologics Consulting Group, Dr. Leininger has also
worked for the U.S. Food and Drug Administration, Chiron, and GlaxoSmithKline.
Elaine Eborall is currently Executive Director, Quality and Compliance for Ultragenyx
Pharmaceutical. Previously she has been with Genentech for 15 years where she was
responsible for the Global GMP Audit Program in the Americas and Asia Pacific regions.
Elaine holds a Bachelor’s of Science in Biology with a minor in Chemistry. She is certified as
a Quality Auditor by ASQ and holds an Advanced Certificate in Regulatory Affairs from the
University of San Diego. Prior to joining Genentech Elaine held positions at Astra-Zeneca
and Centaur Pharmaceuticals in Quality and Regulatory Affairs.
*********************************************************************
BioPharma Consortium, Friday, April 22, 2016
Topic: “How to Develop a Winning Patent Portfolio”
Speakers: John Storella, Intellectual Property Law For Innovators In Biotechnology
Shirley Recipon, Life Science and Intellectual Property Professional
Date andTime: Friday, April 22, 2016, 11:30 AM - 1:30 PM
Networking lunch: 11:30 AM
Seminar: 12:00: PM
Networking & Questions: 1:00 PM
Location: Molecular Medicine Research Institute, 428 Oakmead Pkwy,Sunnyvale, CA 94085
Pricing: Free, but pre-registration is required
RSVP: http://bpcapril2016event.eventzilla.net
Topic Description
9
Building a patent portfolio is much more than filing patent applications on your inventions.
At its best, a patent strategy coordinates technology development with corporate strategy,
market opportunity and competitor analysis. A strong patent portfolio gives a company a
competitive advantage by creating a zone of exclusion for the valuable features of your
product. Patents also protect your freedom to operate by providing defensive and offensive
assets against those who would assert their patents against you. A well conceived patent
strategy makes your company attractive to investors. They also can be monetized through
licensing opportunities.
Speaker Bios:
John Storella advises early stage biotechnology companies about developing and executing
intellectual property strategies. In a career spanning more than 25 years, John has worked
at Fish & Neave (now Ropes & Gray), Townsend and Townsend (now Townsend Kilpatrick),
Ciphergen Biosystems and Wilson Sonsini. He currently practices from his own offices in
Berkeley. His clients have included Biogen, Eli Lilly, Regeneron, Affymetrix, University of
California, Geron, Counsyl, Pathwork Diagnostics, Cellerant Therapeutics, IntegenX,
Ajinomoto Althea and Guardant Health.
Shirley Recipon applies her over 15 years experience as a Patent Agent in delivering US and
foreign patent preparation and prosecution, strategic patent counseling and efficient IP
portfolio management. She enjoys seamlessly merging her scientific knowledge, including
research at Johns Hopkins and the NIH, to protect and advance a company’s IP position.
Her experience includes supporting innovators and business goals and objectives at Incyte,
Applied Biosystems, Life Technologies and DuPont
Contact: http://www.biopharmaconsortium.com/contact/
******************************************************************
Bio2Device Group, Tuesday Morning, April 26, 2016
Topic: “The Ever Changing Startup Environment”
Speaker: Jeffrey J Christian , CEO, Phoenix DeVentures Inc.
Date and Time: Tuesday, April 26, 2016, 8:30 am
Location: Sunnyvale City Council Chambers, 456 West Olive Avenue, Sunnyvale
There is no registration or fees for morning meetings.
Topic Description
Mr. Christian's discussion will focus on the shift from traditional VC backed startups to the
current trend in new MedTech product startups. Phoenix’ experience in these trends ranges
from surgical instruments and delivery device to ophthalmic and cardiac implants with
several examples between. A new potential model for funding and developing medical
devices will be presented.
Speaker Bio
Phoenix DeVentures founder, Jeff Christian, has been in the Medical Device field for 35
years. Initially operating out of Jeff’s garage, Phoenix DeVentures has been servicing
medtech startups for over 15 years, growing to include 60 employees in 40,000 square feet
of development and manufacturing space. In that time Phoenix has seen a broad spectrum
of startup dynamics, with the pendulum swinging from VC’s ‘throwing’ money at some
sectors to the purse strings becoming cinched tight. Phoenix has seen the effect of this
broad swing in its clientele, and has grown year over year for 15 years in spite of the
financial trauma to this industry sector.
*******************************************************************
Bio-X Frontiers, Tuesday, April 26, 2016
10
Topic: “Integration Of Systems Biology, Tissue Engineering, And Microdevices For Drug
Development”
Pre-Seminar Speaker: Ovijit Chaudhuri, Department Of Mechanical Engineering
April 28, 2016
Seminar Speaker: Linda Griffith, Mit --Integration Of Systems Biology, Tissue Engineering,
And Microdevices For Drug Development
Date And Time: Tuesday, April 26, 2016, Noon
Location:
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
Small Lunch Served At 12:00��; Lectures Begin At12:15��
Pre-Seminars In Clark Center Room S361; Seminars In Clark Center Room S360
****************************************************************
HBA, Tuesday Evening, April 26, 2016
Event: HB8 Dine-Around: The State of International Women's Health Today
Speaker: Sally Stephens, Senior vice president, corporate development, Medicines360
Date and time: Tuesday, April 26, 5:30 - 8:00 PM
5:30 - 6:15 PM Networking and appetizers
6:15 - 6:30 PM HBA welcome
6:30 - 7:15 PM Dinner and discussion led by Sally Stephens
7:15 - 8:00 PM Q&A discussion, dessert and networking
Location: Hotel Shattuck Plaza Berkeley, 2086 Allston Way, Berkeley, CA 94704
Rate: Before April 19: $35; After April 19: $45
Registration information
Event is open to: HBA members only
Online registration deadline: April 22, 2016
Onsite (walk-in) registration: Is NOT allowed
Register at https://my.hbanet.org/MyHBA/EventDetails.aspx?MeetingID=1EC2240B-52F8-
E511-998D-0050569C00A7
Event description
May 8 - 14 is National Women's Health Week. As the department of health and human
services and organizations rally to help US women understand the steps they can take to
improve their health, it's hard to not think about the majority of women internationally who
lack access to the basic health services we take for granted in our own county.
Did you know?:
• The number of women worldwide who had an unmet need for modern contraception in
2012 was 222 million
• In Africa, only 29 percent of women of reproductive age use modern contraception and
the average number of
children per woman is 4.7
• 40 percent of girls in sub-Saharan Africa are married before the age of 18
• There are 1.8 billion young people in the world right now (ages 10-24)... 600 million are
adolescent girls. Never
before has there been so many young people.
Join us for an engaging dinner discussion with Sally Stephens, senior vice president,
corporate development at Medicines360, as we take a look at the state of women's health
globally. For organizations like Medicines360, whose mission is to expand access to
medicines for women regardless of their socioeconomic status, insurance coverage or
11
geographic location, the key is to innovate on many different levels in order to meet the still
unmet need in global women's health today.
Learning objectives
1. Gain insight into the current state of global women's health issues
2. Learn about innovations that organizations are exploring to close the gap in women's
health disparity across the world
********************************************************
Qb3, Tuesday Mid Day, April 26, 2016
Topic: “Investment Themes in the New Healthcare Marketplace”
Speaker: Nina Kjellson, General Partner, VC firm Canaan Partners
Date and Time: Tuesday, April 26, noon to 1:00 pm
Location: Room 212, Byers Hall, UCSF Mission Bay
Fee: General Admission - $10
Register at http://www.eventbrite.com/e/qed-nina-kjellson-canaan-partners-
investment-themes-in-the-new-healthcare-marketplace-tickets-
24267515793?mc_cid=bdb6700a62&mc_eid=cb4c38a44a
Topic Description
The healthcare marketplace is changing rapidly, influenced by precision medicine and
devices that inform and empower consumers. Business models are following suit as
pharma, retailers, providers, and payers seek to adapt and profit. Similarly, investors
must anticipate which companies are most likely to succeed. Join us on Tuesday,
April 26, when Nina Kjellson, general partner at VC firm Canaan Partners, will share
her perspective on the most important trends in early-stage healthcare startups.
Speaker Bio
Nina Kjellson joined Canaan healthcare team in the Fall of 2015. She focuses on early-stage
investments in biopharmaceuticals and digital health. Current investment themes include
therapeutics for serious and underserved conditions such as cancer, autoimmune disease
and life-threatening infections; patient/consumer engagement; and IT-enabled
transformation of healthcare delivery. She is co-founder and co-chair of ConsumerMed.org,
a forum to address the convergence of health care and consumer innovation and serves as
a mentor to Blueprint Health, a digital health incubator and Springboard Life Sciences, an
accelerator for healthcare companies driven by women entrepreneurs. She is a member of
the advisory board for the Oliver Wyman Health Innovation Center.
**********************************************************
Naturejobs Career Expo, Wednesday, April 27,2016
Event: Career Expo
Date and Time: Wednesday, April 27, 2016l, 10 AM - 5 PM
Location: Contemporary Jewish Museum (736 Mission St, San Francisco, CA 94103)
Find details and registration at http://www.nature.com/naturejobs/career-
expo/event/naturejobs-career-expo-san-francisco/
Event Description: The Naturejobs Career Expo is the global career fair and conference for
the science community from Naturejobs and Natureconferences. The Naturejobs Career
Expo 2016, hosted for the first time in San Francisco, offers talented researchers an
excellent opportunity to meet a diverse selection of national and international employers
12
from academic institutions and scientific industries, such as pharmaceutical organizations,
digital technology companies, science publishing and more.
* Attend all conferences and workshops for free
* Meet employers face-to-face
* Benefit from one-to-one resume checking
* Network with leading scientific institutions
* Learn how to enhance your employability
* Maximize your career prospects
**************************************************************
WIB-San Francisco Bay Area, Wednesday Evening, April 27, 2016
Topic: “Making the Transition from Academia to Industry”
Panel: Moderator: Maya Benbarak (Genentech) and feature speakers Rebecca Begley
(Gilead), Ellen Shen (Gilead), Linda Yu (23andMe), and Jess Porter Abate (Roche).
Date and Time: April 27, 2016, 5:00 p.m. – 9:00 p.m. PST
5:00 p.m. – 5:30 p.m. Check-in
5:30 p.m. – 6:00 p.m. Networking & Refreshments
6:00 p.m. – 7:30 p.m. Panel Discussion
7:30 p.m. – 9:00 p.m. Questions & Networking
Location: Stanford Engineering Quad Building Y2E2, Room 101, 473 Via Ortega Stanford, CA, 94305
Pricing Information
Members: $5
Non-Members: $35
Register at http://womeninbio.org/eventdetails.aspx?EventId=28612
Event Description
Please join the San Francisco chapter of Women In Bio for an informative panel discussion
on the transition from academia to industry!
The panel will focus on different career paths outside of academia, and how to prepare for
the next step in your career. There will also be opportunities for networking before and after
the panel event, which will include light refreshments.
*************************************************************
BioDesign at Stanford, Monday Evening, May 2, 2016
Event: “Stanford Biodesign, 15 Years of Innovation: Past, Present and Future
Perspectives”
Impressive list of speakers on panel
Date and Time: Monday, May 2, 2016, 5:30 pm,5:30 PM program, 6:30 PM reception
Location: Schwab Residential Center Vidalakis Dining Room, 680 Serra Street.
Stanford, CA 94305
Please RSVP. Questions? Contact [email protected]
Event Description
Please join us for an evening of dialog and hospitality celebrating 15 years of
Stanford Biodesign. Interviews with program leadership and alumni. Exciting
announcements to be made! Cocktail reception and festivities to follow.
***************************************************
Bio2Device Group, Tuesday Morning, May 3, 2016
13
Topic: “Launching telemedicine devices abroad: a case study in CV”
Speakers: Srikanth Jadcherla, CEO and Dr. Rich Goldman, Chief Marketing Officer, PiiTech
Date and Time: Tuesday, May 3, 2016, 8:30 am
Location: Sunnyvale City Council Chambers, 456 West Olive Ave., Sunnyvale, CA
There is no fee nor registration required for morning meetings.
Speaker Bio
Rich Goldman is Chancellor of Global University of Engineering and a consultant to the
semiconductor industry with more than 25 years of global experience developing strategic
alliances, technology standards and marketing programs that align with company strategy
and drive results. In 1986, Rich established Texas Instruments' ASIC operation in
Bangalore, India. In 1992, he founded Russian-American Software, amongst the first US-
Russia collaborations in software. While serving as a vice president at Synopsys, Inc., and
CEO of Synopsys Armenia, Rich helped develop a number of programs to foster high tech
education worldwide, garnering honors such as guest Professor at the Chinese Academy of
Science, and Honorary Professor at the Moscow Institute of Electronic Technologies. With
Michael S. Malone and the President of Armenia, Rich established the Armenia’s Presidential
Award for Contribution to Humanity Through IT, bringing to Armenia Steve Wozniak, Craig
Barrett, and Federico Faggin.
Rich has presented at TEDx, and coauthored the book “STARMUS” with Neil Armstrong,
Buzz Aldrin, Alexi Leonov, Kip Thorne, Richard Stzostak, George Smoot, Steven Hawking,
Brian May, and others. Rich earned a BSCS from Syracuse University, an MBA and MS
Engineering Management from The University of Dallas, and an honorary Doctorate from
The State Engineering University of Armenia.
****************************************************************
Stanford Law Program in Law, Science and Technology, Wednesday, May 4, 2016
Event: Stanford IP Law And The Biosciences Conference
Confirmed Speakers
o Victoria Brewster, Fisherbroyles, Llp
o Trevor Cook, Wilmerhale
o John Duffy, University Of Virginia School Of Law
o Rebecca Eisenberg, University Of Michigan Law School
o Deborah Fishman, Kaye Scholer
o Hon. Arthur Gajarsa, Formerly United States Court Of Appeals For The Federal
Circuit; Wilmerhale
o Robert Galvin, Wilmerhale
o Hon. Paul Singh Grewal, United States District Court For The Northern District Of
California
o Hon. Faith Hochberg, Formerly, United States District Court For The District Of New
Jersey
o Hon. Susan Illston, United States District Court For The Northern District Of
California
o William "Bill" Lee, Wilmerhale
o Mark Lemley, Durie Tangri Llp; Stanford Law School
o Michael Lisi, Ariosa Diagnostics
o Lisa Larrimore Ouellette, Stanford Law School
o Arti Rai, Duke University School Of Law
o Hon. James Selna, United States District Court For The Central District Of California
o Hon. Gregory Sleet, United States District Court For The District Of Delaware
14
o Laura Storto, Genentech
o John "Jay" Thomas, Georgetown Law
Date and Time: Wednesday, May 4th, 2016, 8:30 am – 5:15 pm
Location: Stanford University, Paul Brest Hall, 555 Salvatierra Walk, Stanford, CA 94305
This event is open and free to the public, but registration is required. For more information,
to view the agenda, and to register, Register At
Http://Web.Stanford.Edu/Dept/Law/Forms/2016iplaw.Fb
For questions and information:
E:mail: [email protected]
Phone: 650 723-5905
Event Description
Join Us On May 4, 2016 From 8:30 A.M. To 5:15 P.M For The Stanford Ip Law And The
Biosciences Conference, An Informative Discussion With Leading Experts From Academia,
Industry And The Judiciary On The Latest Developments In Intellectual Property Law And
The Biosciences. Judges, Top Legal Scholars And Experienced Practitioners From Across The
Country Will Examine Some Of The Key Legal And Policy Issues Raised By The Biosciences
Industry.
Panels
o Patent Litigation In The Biosciences Circa 2016: A View From The Bench
o Biosimilars
o Patentable Subject Matter In A Post-Myriad And Post-Alice World
o Trade Secrecy, Data Exclusivity, Regulation And Other Alternatives To Patent
Protection In The Biotech Space
o Luncheon Keynote
************************************************
Bio-X, Saturday, May 7, 2016
In vitro Vascularized Constructs as Models of Metastatic Cancer
Date and Time: Saturday, May 7, 2016, noon
Location:
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
SMALL LUNCH SERVED AT 12:00��; LECTURES BEGIN AT12:15��
PRE-SEMINARS IN CLARK CENTER ROOM S361; SEMINARS IN CLARK CENTER ROOM S360
Pre-Seminar Speaker: Alexander Dunn, Department of Chemical Engineering
May 19, 2016
Seminar Speaker: Roger Kamm, MIT
In vitro Vascularized Constructs as Models of Metastatic Cancer
*****************************
CABS, Saturday, May 7, 2017
Event: 2016 BioPacific Conference
Date and Time: Saturday, May 7, 2016, 8 AM- 9 PM
Location: San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402
Registration:
Refreshments, lunch and dinner are included for all registrants
CABS Member Early Bird Registration
(before 04/15/16)
Regular Registration
(04/16/16 - 04/30/16)
Late Registration
(after 04/30/16)*
General $65 $100 $200
Student/Postdoc** $50 $80 $160
15
Non-Member Early Bird Registration
(before 04/15/16)
Regular Registration
(04/16/16 - 04/30/16)
Late Registration
(after 04/30/16)*
General $125 $160 $260
Student/Postdoc** $110 $140 $220
*No guarantee on lunch and dinner
Register at
http://www.cabsweb.org/events/2143408/Registration+is+Open%3A+2016+BioPacific+Co
nference/
Description:
Our meeting will showcase:
Winner of 2016 CABS K. Fong Award in Life Sciences
Most promising areas in life sciences
Opportunities and challenges for developing biopharmaceuticals in China
Cross border financing and entrepreneurship
Success stories of entrepreneurs and emerging companies
Confirmed Speakers and Panelists include:
Hari Kumar, CEO, Adheron Therapeutics
Piers Whitehead, EVP & CBO, PaxVax
Mark Selby, Ph.D., Senior Director of Immuno-Oncology, Bristol- Myers Squibb
Edward F. Chang, M.D., Associate Professor of Neurological Surgery and Physiology,
Co-Director, Center for Neural Engineering and Prostheses at UC Berkeley and UCSF,
New York Stem Cell Foundation- Robertson Investigator University of California,
San Francisco
Lei Stanley Qi, Ph.D., Assistant Professor, Department of Bioengineering and of
Chemical and Systems Biology, faculty fellow in the interdisciplinary Institute for
Chemistry, Engineering, and Medicine for Human Health
Shawn Qian, Ph.D., CEO, Neupharma
Xiaodong Yang, M.D., Ph.D., President and CEO, Apexigen
Xian-Ping Lu, Ph.D., Co-Founder, CEO and CSO, Chipscreen Biosciences
Dan Zhang, M.D., Ph.D., CEO, Fountain Medical Development
Yongmei "Alexis" Ji, Ph.D., MBA, Principal, WuXi Ventures
James Zhao, M.D., M.S., MBA, Founding Partner, LYFE Capital
Yuwen Liu, MBA, MS, Founding Partner, BoHe Angel Fund
Min Cui, Ph.D., Founding Partner and Managing Director, Decheng Capital
This highly anticipated full day event is expected to attract over 600 life science
professionals from San Francisco Bay Area as well as Pacific Rim countries.
Contact for Sponsorship/Exhibition Opportunities: [email protected]
*************************************************************************
Bio2Device Group, Tuesday Evening, May 10, 2016
Topic: Is discovery research a luxury or a necessity in biotech?
Speaker: Austin Gurney, Ph.D, CSO, Senior VP, Molecular and Cellular Biology, Oncomed
Date and Time: Tuesday, May 10, 2016, 6:00-9:00 pm
Location: Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins
16
Payment Options
We use PAYPAL to process your online payment. Print and bring a copy of your online
receipt with you. If space permits, walk-ins are welcomed; please be prepared to pay $20
cash or check. There is no refund, exchange, or transfer. Thank you for your cooperation.
To register now, select the appropriate registration level and your meal preference from the
pull-down menus below and enter the name and email of the attendee. Then click on the
"Pay Now" button to reach the PayPal payment page. Each attendee must be registered
separately. Please register a non-member by logging out first.
Make sure you enter the attendee's meal choice, name, and email address.
Register at www.Bio2DeviceGroup.org starting the weekend of April 23-24, 2016
Topic Description
Building a biotech company is challenging for a multitude of reasons. Among the greatest
challenges is the difficulty financing a company though the long journey towards the
creation of new medicine. Research, particularly basic discovery research is often perceived
as a cost and burden which needs to minimized in order to marshal resources towards the
advancement of a lead clinical program. However, it can be argued that creating “the next
Genentech” will remain metaphor rather than reality without investment in research by new
biotechs. I will share our experiences and observations building a biotech anchored on a
model of ongoing and substantial investment in basic discovery research. Among our
surprising observations: rather than being a cost, research has funded the company!
Speaker Bio
Austin Gurney joined OncoMed Pharmaceuticals at its founding as Vice President of
Molecular and Cellular Biology. Prior to OncoMed, Dr. Gurney worked at Genentech where
his research contributed to the discovery of numerous growth factors and cytokines. He has
authored or co-authored more than 60 papers and is listed as an inventor on over 600
patents related to therapeutic applications in immunology and cancer. Dr. Gurney has two
decades of experience in biotechnology and in the development of novel therapeutics.
Dr. Gurney conducted his Ph.D. work at Case Western Reserve University. He completed
post doctoral studies with Dr. Bryan Williams at the Cleveland Clinic, and at Genentech with
Dr. David Goeddel.
*************************************************************************
sfAWIS, Wednesday Evening, May 11, 2016
Topic: "The Conflict Shift: from Conflict to Cooperation"
Speaker: Susan Berstein, MBA, PhD
Date and Time: Wednesday, May 11, 2016, 6:30 pm
*********************************************************************
RAPS, Wednesday Afternoon, May 11, 2016
Topic: “Navigating US Market Access Landscape for Optimal Regulatory and Business
Strategy”
Speaker: Speaker:
Jane Horvath, MHSA, market access lead, 3D Communiations
Date and Time: Wednesday, May 11, 2016, 5:30 - 8:00 pm
Wednesday, 11 May 2016
5:30 pm Registration Check-in, Light Dinner
6:00 pm Welcome and Opening Comments
6:15 pm Presentation
17
7:15 pm Open Discussion/ Q&Q Session
7:45 pm Program Concludes
Location: Johnson & Johnson, 6500 Paseo Padre Pkwy, Fremont CA 94555
Prior to 4 May:
RAPS Members: $25
Nonmembers: $35
On or After 4 May:
RAPS Members: $35
Nonmembers: $45
More Information >
Register at https://raps.org/EventDetails.aspx?ProductId=93225532
Topic Description
Meet your regulatory colleagues from across the San Francisco Bay area during an expert
presentation on “Navigating US Market Access landscape for Optimal Regulatory and
Business Strategy,” with Jane Horvath, MHSA.
Topics to be covered include:
• A review of basic of Medicare coverage and reimbursement policies and practices
• An understanding of key changes in the US commercial healthcare market that affect
access\
• How to address more vocal and new stakeholders influencing market access
• Best practices for how to enter the US market with better value communications by
starting early in the development process
This meeting is sponsored by the RAPS San Francisco Chapter and is intended to promote
knowledge advancement and facilitate networking among local regulatory professionals. A
light meal will be available and attendees may claim two (2) RAC recertification credits.
A valid photo identification will be required to enter the premises. Participants will not be
able to gain access without a Photo ID.
Speaker Bio
Jane Horvath, MHSA, leads 3D's Market Access and Value Communications team. Jane
brings nearly 25 years of experience in health policy and reimbursement issues to 3D
clients. As Executive Director of Health Policy and Reimbursement at Merck for a decade,
she identified the business implications of state and federal policy developments including
the Medicare prescription drug program, Medicaid, health information technology, Big Data
access and methods, 340B, and reformed commercial markets. Prior to Merck, Jane was
Deputy Director of the Robert Wood Johnson Foundation project at Johns Hopkins University
School of Public Health, conducting research and devising policy on care management and
financing for people with chronic conditions. Jane also held a series of high profile
government positions. This included work as Deputy Assistant Secretary for Legislation in
the US Department of Health and Human Services, responsible for legislative policy for all
health-related areas, including Medicare, Medicaid, and prescription drug pricing. Recently
Jane was Vice President at Breakaway Policy Strategies focused on biopharma issues and
clients. Jane earned a Masters of Health Services Administration from the George
Washington University.
******************************************************************
HBA San Francisco, Thursday Morning, May 12, 2016
Event: “2016 Woman of Year Event – West”
Date and Time: Thursday, May 12, 2016, 8:00 – 11:00 am
18
8:00 - 8:30 AM Check in and networking
8:30 - 8:40 AM Welcome and opening remarks
8:40 - 9:25 AM Leadership panel
9:25 - 11:15 AM Live broadcast into WOTY, awards and networking
10:15- 11:00 AM Dress for success, raffle, networking and closing remarks
Event location
Genentech
611 Gateway Blvd., Building 82
South San Francisco, CA 94080
650-225-1000
Details and registration at
https://my.hbanet.org/MyHBA/EventDetails.aspx?MeetingID=C6A15543-C9DC-E511-A054-
0050569C00A7
Event Description
HBA celebrates Jennifer Cook, head of pharma for Europe region at Roche, as our 2016
Woman of the Year (WOTY). In addition, we will celebrate the 2016 Honorable Mentor
Jacopo Leonardi, executive vice president and president, Immunology at Baxalta
Incorporated, and nearly 100 Rising Stars and Luminaries.
At Genentech, we will participate in WOTY via a live satellite over breakfast. In addition to
the live feed, we will hear from a variety of senior leaders from Genentech, Deloitte and
other San Francisco companies and also provide the opportunity for networking throughout
the event.
******************************************************************
Stanford Medicine, Saturday, May 14, 2016
Topic: “Health Matters 2016”
Date and Time: Saturday, May 14, 9:00 a.m. – 2:00 p.m.
Location: Li Ka Shing Center for Learning and Knowledge, 291 Campus Drive, Stanford
Registration opens on April 1.
Details at http://healthmatters.stanford.edu/
Podcasts and videos of the 2015 event are also listed.
Topic Description
health matters is a free community event hosted by Stanford Medicine that explores the
latest advancements in medicine and the health topics that matter most to you and your
family.
****************************************************************
NCC-AWIS, Tuesday Evening, May 17, 2016
Event: Annual Awards and Recognition Banquet
Keynote Address Speaker: Susanne Lindgren, PhD, professor at Cal State
University, Sacramento and was the 2015 Judith Pool Award recipient.
Date and Time: Tuesday, May 17th: 6:00pm - 9:30pm
Rate
Member: $25
Non-member: $35
Student: $20
Genetech employee: $15
19
Location: Dominic's at Oyster Point: South San Francisco
Advance RSVP required
Event Description
The AWIS Northern California Chapters' Annual Awards & Recognition Banquet is
approaching. We cordially invite you to join us for a lovely dinner party and inspiring
evening.This annual event, hosted by AWIS-NCC brings together four chapters to celebrate
three distinguished women scientists being recognized for mentorship. Early bird ticket
special available through May 9th.
RSVP for the ceremony today!
Fees and registration at http://www.brownpapertickets.com/event/2533796
Join us for our annual celebration of women in science:
Mingle, enjoy wine and appetizers, and then stay for a lovely buffet dinner
and ceremony
Reconnect with friends and make new ones from around the bay
Be inspired by personal stories of excellence in science and mentoring
Leilani Miller, PhD, of Santa Clara University will receive the 2016 Judith Pool Award.
Wendy Fantl, PhD, of Stanford University will receive the 2016 Ellen Weaver Award.
Tracy Lin, RPh, of Johnson & Johnson will receive the 2016 Sherrie Wilkins Award.
Reserve your banquet ticket now. Registration is $40 through May 9th, and $50 May 10-16.
No onsite registration.
**************************************************************
BioPharmaPM, Wednesday, May 18, 2016
Event: “2016 BioPharmaPM annual conference: "Strategic and Business Management,
Leadership, & Technical Project Management: Leveraging the PMI Talent Triangle in
BioPharma"”
Date: Wednesday, May 18, 2016.
Details and registration at https://www.biopharmapm.org/conference
We are also taking advantage of technology and holding the conference at two locations via
videoconference to enable and encourage greater participation. Our sponsors for the event,
Genentech and Pfizer, have graciously offered to host the event at their facilities in South
San Francisco and La Jolla, California, respectively. We will have speakers and networking at
each site, so if you are local to these facilities, or able to travel, please plan on attending.
The registration fee is $299 for the one-day conference and for 2016, we are including an
annual membership to the organization in the cost. Registration is a two-step process on
our website: 1) Pay for the conference and 2) Complete the registration. Following
payment, please "Register for the Conference" to register your name so you receive all
updates as the conference date approaches.
The conference will be held on May 18th at two locations via videoconference. Our sponsors
for the event, Genentech and Pfizer, have graciously offered to host the event at their
facilities in South San Francisco and La Jolla, California, respectively. We will have speakers
and networking at each site, so if you are local to these facilities, or able to travel, please
plan on attending. Given our sponsors' generosity, Genentech and Pfizer colleagues will be
eligible for a significant discount on the registration fee. If you are a colleague at a
sponsoring organization, please contact me directly at [email protected] on
how to access this discount.
20
Registration is limited to 100 participants per location, so register soon! We look forward to
seeing you at the conference!
*****************************************************************
JLABS, Thursday, May 19, 2016
Event: “WORKSHOP 3 | Lessons Learned: The IPO process from battle tested
Veterans”
Speakers:
Linda Bain | Chief Financial Officer, Codiak BioSciences read bio»
Isaac Ciechanover | President & CEO, Atara Biotherapeutics read bio»
[moderator] Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte &
Touche LLP
Date and Time: Thursday, May 19, 2016, 8:15 am
Agenda:
8:15 AM | Registration Opens, Breakfast and Networking
9:00 AM | Panel and Q&A
10:30 AM | Closing remarks and networking
11:00 AM | Program Close
Location: JLABS @ SSF, 329 Oyster Point Blvd - 3rd Floor, South San Francisco, CA
Day 3 Fees: $20 | General Public: $35 | At the door
Register at http://www.eventbrite.com/e/how-to-ipo-series-tickets-
20106147027?aff=blast#Day3
Event Description
There is nothing like experience! The final event in our 3 part IPO series with Deloitte
& Touche, LLP brings in two high profile C-level executives. They have gone through
the IPO experience and as IPO journey's go, their paths were different.
This breakfast event will take a look at two companies that recently went through
successful IPO's. The company leaders will share their insights from firsthand
experience on issues ranging from preparation to execution.
Topics include:
Hiring the right professional team
Managing the Board
The roadshow
Pricing, timing and market conditions
The surprises, pitfalls and lessons learned
With plenty of time for Q&A
Join us for an insider's look at the IPO!
Speakers' Biographies:
Linda Bain | Chief Financial Officer, Codiak BioSciences
Linda Bain joined Codiak from Avalanche Biotechnologies where, as chief financial
officer, she led a successful IPO and follow-on financing. She previously served as
vice president of finance, business operations and treasurer at Bluebird Bio. Ms. Bain
has held senior roles at Genzyme Corporation, including vice president of finance,
global manufacturing and operations and vice president of finance of Genzyme
Genetics. Earlier in her career, she served in senior finance roles at Fidelity
Investments and AstraZeneca Pharmaceuticals and as an auditor at Deloitte &
Touche.
21
Isaac Ciechanover, M.D. | President & CEO, Atara Biotherapeutics
Dr. Isaac Ciechanover is a physician, investor and entrepreneur driven by a passion
to improve the practice of medicine. Motivated by the belief that the majority of
medical discoveries still lie ahead, he has dedicated the past 20 years to working
with entrepreneurs and life sciences organizations to advance medicine through
innovation and technology. He founded Atara Biotherapeutics in August 2012.
Previously, he was a partner in the life sciences practice at Kleiner Perkins Caufield &
Byers. Earlier as Celgene's Executive Director for Business Development, he
spearheaded the company's venture capital efforts and led licensing and M&A
activities with an aggregate value of more than $6.7 billion. Also at Celgene, he was
Global Project Leader for the company's first clinical-stage biologic therapy. Isaac has
also held business development and venture capital roles at Amylin Pharmaceuticals,
Pequot Ventures' healthcare practice and Pfizer. Intellectually curious (and
undeterred by student debt), Isaac holds a B.A. from Stanford University, an M.Phil.
in Epidemiology from Cambridge University, an M.D. from Weill Cornell Medical
College and an M.B.A. from Harvard Business School. For fun, he enjoys cycling,
scuba diving and building Lego with his two children. His all-time favorite albums are
Pink Floyd's "The Dark Side of the Moon," Radiohead's "OK Computer" and Ruggero
Leoncavallo's Italian opera, Pagliacci, with Herbet Von Karajan conducting.
Angela Rusakova | West Region Life Sciences Audit Partner, Deloitte & Touche LLP
Angela has 20 years of experience serving both public and private companies with a
focus on the life sciences industry. She works with companies in all stages of growth,
from start-ups to SEC registrants. Her technical background includes complex
accounting issues such as revenue recognition, equity, derivatives, stock-based
compensation, and acquisitions. Angela has been involved in financing and M&A
transactions, including initial public offerings, offerings in leveraged buyouts, and
several secondary shares offerings. She has extensive international experience and is
a certified public accountant in the United States and the United Kingdom. Angela
also served as a CFO before returning to public accounting in 2003.
**********************************************************************
QB3, Thursday Mid Day, May 19, 2016
Topic: “How to Navigate US Immigration Law for Biotech Entrepreneurs”
Speakers: Norman Plotkin and Atessa Chehrazi, partners at the immigration law firm of
Jackson & Hertogs
Date and Time: Thursday, May 19, noon to 1:00 pm
Location: Room 160, Helen Diller Bldg. (1450 Third St.), UCSF Mission Bay
Fee: General Admission - $10
Register at http://www.eventbrite.com/e/qed-norman-plotkin-and-atessa-chehrazi-how-to-
navigate-us-immigration-law-for-biotech-entrepreneurs-tickets-
21686104723?mc_cid=1a27eae361&mc_eid=cb4c38a44a
Topic Description
Biotech companies want to hire talented employees with the right skills but many
candidates may need to be sponsored by the employer because they might not be US
citizens or permanent residents. What are the options for entrepreneurs starting up
businesses? How can a founder establish an immigration policy to attract and retain the best
and the brightest? What visa options are available and how best to navigate through US
immigration laws? Norman Plotkin and Atessa Chehrazi, partners at the immigration law
firm of Jackson & Hertogs, will explain how the most common visas such as H-1B, J-1, and
22
TN work and will discuss recent developments in immigration law including changes to the
F-1 STEM OPT work authorization.
What you'll learn
• How US immigration laws work and what the differences are between the H-1B, J-1,
O-1, and TN visas
• How to establish an internal immigration program or navigate an employer’s
immigration program
• The most recent developments in immigration law
Speaker Bios
Norman became a partner in February 2002. Throughout his career, Norman has
been active in AILA. Previously, he served as the editor of the Gold Book, a resource
for practicing immigration law in California, and as co-editor of the Western Region
Directory for the Immigration Practitioner. He was also liaison for the Northern
California AILA Chapter to both the California Service Center and the U.S.
Department of Labor. In addition, he was a member of the national AILA/California
Service Center liaison committee and previously served on the national
AILA/Department of Labor liaison committee. He has also lectured at seminars and
conferences including national AILA Conferences, the BIO International Convention,
the BIO Human Resources Conference and the HR Star Conference. Norman has
received high marks in all legal directories, including a listing in the Best Lawyers in
America. He is fluent in Spanish.
Atessa has been a partner at Jackson & Hertogs since April 2013 and an
associate/senior associate since July 2000. She was previously an associate at
Maggio & Kattar in Washington, D.C. from 1996 to 2000. She has held several
volunteer roles within the American Immigration Lawyers Association (AILA) during
her career. For AILA’s Northern California Chapter, she has served as Chair, Vice-
Chair, Treasurer, U.S. Citizenship & Immigration Service (USCIS) liaison, and
Customs & Border Protection (CBP) liaison. On a national level, Atessa served on
AILA’s USCIS Headquarters and Benefits, Administrative Appeals Office (AAO), and
Department of Labor (DOL) liaison committee. In addition, Atessa has served on
AILA’s Business Immigration Advocacy, Issues, and Due Process & Civil Liberties
committees, as well as several conference committees. She has served as a board
member of the Iranian American Bar Association Northern California chapter since
2009 and is incoming President of the chapter. She is a member of the Bar
Association of San Francisco, and the National Lawyers Guild. She has authored
several articles published in AILA Handbooks. Atessa has presented at national and
regional AILA conferences. Atessa has been highly reviewed in legal directories,
including selection as a Northern California “Super Lawyer” (2010-2012), and listing
in the International Who’s Who of Corporate Immigration Lawyers (2011-2015).
*************************************************************************
QB3, Thursday Mid Day, May 20, 2016
Topic: “How to Navigate US Immigration Law for Biotech Entrepreneurs”
Speakers: Norman C. Plotkin and Atessa Chehrazi, partners at Jackson & Hertogs
Date and Time: Thursday, May 19, noon to 1:00 pm
Location: Room 160, Helen Diller Bldg., 1450 3rd Street, UCSF Mission Bay, San
Francisco, CA 94158
Fee: General Admission - $10
23
Register at http://www.eventbrite.com/e/qed-norman-plotkin-and-atessa-chehrazi-
how-to-navigate-us-immigration-law-for-biotech-entrepreneurs-tickets-
21686104723?mc_cid=57b60d27b3&mc_eid=cb4c38a44a
Topic Description
Biotech companies want to hire talented employees with the right skills but many
candidates may need to be sponsored by the employer because they might not be US
citizens or permanent residents. What are the options for entrepreneurs starting up
businesses? How can a founder establish an immigration policy to attract and retain the best
and the brightest? What visa options are available and how best to navigate through US
immigration laws? Norman Plotkin and Atessa Chehrazi, partners at the immigration law
firm of Jackson & Hertogs, will explain how the most common visas such as H-1B, J-1, and
TN work and will discuss recent developments in immigration law including changes to the
F-1 STEM OPT work authorization.
What you'll learn
• How US immigration laws work and what the differences are between the H-1B, J-1,
O-1, and TN visas
• How to establish an internal immigration program or navigate an employer’s
immigration program
• The most recent developments in immigration law
Speaker Bios
Norman C. Plotkin
Norman became a partner in February 2002. Throughout his career, Norman has
been active in AILA. Previously, he served as the editor of the Gold Book, a resource
for practicing immigration law in California, and as co-editor of the Western Region
Directory for the Immigration Practitioner. He was also liaison for the Northern
California AILA Chapter to both the California Service Center and the U.S.
Department of Labor. In addition, he was a member of the national AILA/California
Service Center liaison committee and previously served on the national
AILA/Department of Labor liaison committee. He has also lectured at seminars and
conferences including national AILA Conferences, the BIO International Convention,
the BIO Human Resources Conference and the HR Star Conference. Norman has
received high marks in all legal directories, including a listing in the Best Lawyers in
America. He is fluent in Spanish.
Atessa Chehrazi
Atessa has been a partner at Jackson & Hertogs since April 2013 and an
associate/senior associate since July 2000. She was previously an associate at
Maggio & Kattar in Washington, D.C. from 1996 to 2000. She has held several
volunteer roles within the American Immigration Lawyers Association (AILA) during
her career. For AILA’s Northern California Chapter, she has served as Chair, Vice-
Chair, Treasurer, U.S. Citizenship & Immigration Service (USCIS) l iaison, and
Customs & Border Protection (CBP) liaison. On a national level, Atessa served on
AILA’s USCIS Headquarters and Benefits, Administrative Appeals Office (AAO), and
Department of Labor (DOL) liaison committee. In addition, Atessa has served on
AILA’s Business Immigration Advocacy, Issues, and Due Process & Civil Liberties
committees, as well as several conference committees. She has served as a board
member of the Iranian American Bar Association Northern California chapter since
2009 and is incoming President of the chapter. She is a member of the Bar
Association of San Francisco, and the National Lawyers Guild. She has authored
several articles published in AILA Handbooks. Atessa has presented at national and
regional AILA conferences. Atessa has been highly reviewed in legal directories,
24
including selection as a Northern California “Super Lawyer” (2010-2012), and listing
in the International Who’s Who of Corporate Immigration Lawyers (2011-2015).
********************************************************************
South Bay HBA, Saturday, June 4, 2016
Event: South Bay Coffee Chat
Location: Shoreline Lake American Bistro - 3160 N Shoreline Blvd., Mountain View, CA
To RSVP or for more information, please contact Meggin Taylor or Mary Dosunmu
*************************************************************************
BIO International Conference, June 6 – 9, 2016
Dates: June 6 – 9, 2016
Location: Moscone Convention Center, North, South and West Halls
Fees: Convention Access - $1,200, Members and 1,450, Non Members before April 16;
$1,400, Members and $1,750 for nonmembers after April 16 (see other package pricing at
http://convention.bio.org/register/)
*****************************************************************
WIB, Monday Afternoon, June 6, 2016
Topic: Women in Bio Plenary Event at BIO Convention: “The Influential Paths of Great
Visionary Leaders”
Speakers include: Firelli Alonso, Senior Director, Biotherapeutics and Vaccines Outsourcing,
Pfizer; Lisa Cohen, Executive Director, Washington Global Health Alliance; Renee Compton
Ryan, Vice President, Venture Investments, Johnson & Johnson; Bahija Jallal, Executive Vice
President, AstraZeneca, Head of MedImmune
Date and Time: Monday, June 6, 2016, 4:00 – 7:00 pm
Location: Clift Hotel, 495 Geary Street San Francisco, CA, 94102
Walk-Ins Accepted?
Yes*
* - Walk-ins will be accepted at the door until event capacity is reached.
Pricing Information
Members
Early bird rate through May 6, 2016: $60
Regular rate through June 2, 2016: $80
Late/walk-in rate beginning June 3, 2016*: $100
Non-Members
Early bird rate through May 6, 2016: $90
Regular rate through June 2, 2016: $110
Late/walk-in rate beginning June 3, 2016*: $130
* - Late/walk-in pricing will be effective at the door on-site.
On-Line Registration Deadline
June 3, 2016
Register at http://www.womeninbio.org/eventdetails.aspx?EventId=28587
Topic Description
In conjunction with the Biotechnology Innovation Organization (BIO) International
Convention, please join us for our signature annual WIB Plenary Event on Monday, June 6,
2016, at the beautiful Clift Hotel. Our panel of esteemed speakers will discuss critical, and
often controversial, issues affecting women in the life sciences industry, identify important
industry trends and how to act on them, and how they created their career paths. This
panel is sure to inspire and motivate both women and men to work together to support the
career development of women!
25
Date and Time: Monday, June 6, 2016, 4:00 – 6:00 pm
As with all WIB events, our Plenary Event encompasses an inviting and fun environment for
networking as it brings together people from all corners of the life sciences industry, and
spawns new career and business opportunities.
This event is not to be missed so register today!
*****************************************************************
BIO Career Fair, Thursday Afternoon, June 9, 2016
Event: BIO Career Fair
Date and Time: Thursday, June 9, 2016, 2:00 – 7:00 pm
Cost: Free
Details and registration at http://convention.bio.org/careerfair-jobseekers/
BIO is proud to announce the 2016 BIO Career Fair, Thursday June 9 from 2:00 - 7:00 pm.
As an extension of BIO’s online job board—Bio Jobs—the Career Fair will provide an
opportunity for meeting participants and top employers to discuss career opportunities..
The BIO Career Fair (is free) and will allow you access to many of the world’s leading life
science companies. A minimum of a 4-year life science degree OR a community college
biotech degree is recommended and military veterans are encouraged to apply. Details at
More information coming soon!
*********************************************************************
HPLC, Sunday, June 19, 2016
Topic: “HPLC 2016 - 44th International Symposium and Exhibit on High Performance Liquid
Phase Separations and Related Techniques”
Date and Time: Sunday, June 19, 2016 , 8:30 am
Location: Mariott San Francisco Marquis
The goal of HPLC 2016 is to bring together scientists who use and develop
HPLC, capillary electrophoresis, supercritical fluidic chromatography, microfluidics, and mass
spectrometry to exchange ideas, best practices, and
latest developments. The conference program is guided by emerging trends in
separations technology and their impact on science and society.
THREE SESSION TRACKS AT HPLC 2016:
Technology: Better, Faster, Quantitative Separations
Interface to MS: Improving Information Content
BioAnalysis and Applications: Impacting Science and Society
Topics include column and stationary phase technology, interface to mass spectrometry,
microfluidic systems, capillary electrophoresis, LCxLC, QA&QC methods, QbD in separations,
and application to real world problems. A special emphasis in applications will be on
bioanalysis including:
pharmaceuticals, antibody-drug conjugates, antibody characterization, biotechnology,
proteins and proteomics, glycomics, metabolomics and lipidomics, food and nutrition, well-
characterized biologicals, biofuels, environment, and toxicology.
Also Featuring:
Tutorials, Short Courses, User Group Meetings, and Lunch Technical Sessions
For more information, visit: www.hplc2016.org
http://www.hplc2016.org/index.html
Type of Registration: Fees are posted under the "Online Registration" tab located at
www.HPLC2016.org.
Payment must be made by check or credit card payable in US Dollars and drawn on a US
bank (no bank wire transfers).
Registration is not accepted or acknowledged until payment is received.
26
By submitting this registration, you authorize the HPLC 2016 meeting to share your
information with attendees, etc.
Student Registrants: In order for the student rate to be accepted, must submit proof of
current full-time graduate or undergraduate, not postdoctoral, status at an academic
institution by providing both a copy of your Student I.D and a letter on university stationery
from your department chair along with the department chair contact details and email.
Email the letter and copy of the Student ID to [email protected].
All Oral and Poster Presenters: In order to present, the presenting author of each lecture
and poster must be registered as a conference attendee (not booth staff) and must
complete the registration process by paying online by April 18 to confirm intent to attend
and present at the meeting. If fees are not paid, submissions from that author will be
removed from the program.
Refund Policy: A processing fee of 20% will be collected on cancellations on or before April
1, 2016, after which the fees are non-refundable. Registration is transferable; must contact
Symposium Manager by no later than one week prior to the conference to transfer and
receive confirmation of the transfer of the registration ([email protected] or
telephone 301-668-6001).
HPLC 2016 Symposium/Exhibit Manager
Ms. Janet Cunningham
Barr Enterprises
www.LinkedIn.com/in/BarrEnterprises
phone 301-668-6001
www.HPLC2016.org
***********************************************************
PBSS Workshop, Monday, June 27, 2016
Workshop
Topic: “UHPLC in Biopharmaceutical Analysis: Benefits, Practices, Issues and
Implementation”
Speakers: Dr. Michael W. Dong, MWD Consulting
Date and Time: Monday, June 27, 2016, 8:45-12:30
Registration fee (US$): (USD$)Regular: $125; For vendor-show reps: $25; For unemployed
& students: $20; For major-sponsor rep (incl lunch): $0;
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Agilent
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:6/23/2016 (it will close sooner if the seating cap is reached)
About the Topic
Ultra-high-pressure liquid chromatography (UHPLC) is the new standard HPLC platform
delivering higher performance with small-particle columns used on low-dispersion systems
with pressure limits of 15,000 – 23,000 psi. This intermediate-level 1/2-day training
workshop will provide a critical overview the fundamental concepts, benefits, potential
issues, and best practices of UHPLC in pharmaceutical analysis of small molecule drugs and
recombinant biologics (monoclonal antibodies, mAbs)
Who Should Attend
This workshop is intended for analysts, managers, and researchers wishing to have a
thorough understanding the fundamentals and practices of UHPLC in pharmaceutical
analysis. A basic knowledge of HPLC is assumed and some practical hands-on experience is
highly recommended.
Workshop Agenda
27
UHPLC 1: Concept and Benefits
1. Overview and perspectives, Glossary, the modern HPLC platform with higher
performance, UHPLC concepts (the need for high pressure, void volume, peak
volume, instrumental bandwidth), UV flow cell design, dwell volume.
2. Benefits and case studies: Very fast separations with good resolution, very high
resolution analysis of complex samples, facilitating rapid method development,
flexibility to customize resolution, a modernized generic method for most drugs, a
greener HPLC platform.
UHPLC 2: Potential Issues, Practices, and implementation
1. Potential issues and how to mitigate (viscous heating, operating nuances,
compatibility to existing methods, injection precision, detector sensitivity vs. mixing
volumes.
2. Method translation (transfer) issues: method portability, method conversion
(translation), “What is method transfer?”, need for partial method validation, case
studies.
3. How to transition from HPLC to UHPLC, end-fittings, system performance tradeoffs,
Myths in UHPLC, references.
Learning Outcomes UHPLC in Biopharmaceutical Analysis
The attendee will learn the benefits, best practices and potential issues of UHPLC in
pharmaceutical analysis including method translation and how to get started in UHPLC.
About the Speakers
Dr. Michael W. Dong is a principal consultant in MWD Consulting focusing on consulting and
training services on HPLC/UHPLC, pharmaceutical analysis and drug quality. He was
formerly Senior Scientist in Analytical Chemistry and Quality Control at Genentech,
Research Director at Synomics Pharma, Research Fellow at Purdue Pharma, and Senior Staff
Scientist at Applied Biosystems / Perkin-Elmer. He holds a Ph.D. in Analytical Chemistry
from the City University of New York, and a certificate in Biotechnology from U. C. Santa
Cruz. He has 100+ publications including a bestselling book on chromatography (Modern
HPLC for Practicing Scientists). He is an editorial advisory board member of LCGC magazine
and American Pharmaceutical Review.
*************************************************************
PBSS, Friday MidDay, July 29, 2016
Seminar luncheon
Topic: “CRISPR gene editing platform development for drug discovery and validation”
Speakers: Benjamin Haley, PhD (Genentech)
Organizers:
Date: Friday, July 29, 2016, 11:00-13:30
Registration fee (US$): (USD$);
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:7/27/2016 (it will close sooner if the seating cap is reached)
******************************************************************
Bio2Device Group, Tuesday Evening, August 9, 2016
Topic: TBA
Speaker: Dr. Allison Dupuy, Partner, Simon-Kucher
Date and Time: Tuesday, Aug. 9, 2016, 6:00 pm
Date and Time: Tuesday, Oct. 13, 2015, 6:00pm
28
Location: Wilson Sonsini Goodrich & Rosati, 650 Page Mill Road, Palo Alto CA
Cost:
$6 - Students/In-transition - Members only
$11 - Early-bird Registration - Members only
$20 - Late Registration and Non-Members
$25 - Walk-ins (as space permits)
Register at www.Bio2DeviceGroup.org
Speaker Bio
Dr. Allison Dupuy is a Partner in the Life Sciences division of Simon-Kucher & Partners in
San Francisco and leads the company’s life sciences practice on the west coast of the
US. She joined the team in San Francisco in August 2012 after spending 5 years in
Simon-Kucher’s Boston office.
In her work at Simon-Kucher, she focuses on strategic pharmaceutical marketing, value-
to-customer, market entry strategies, pricing and market access strategies, innovative
pricing strategies, product lifecycle strategies, licensing and valuation, market
forecasting and value communication, including global value story development and
implementation. She is a trusted advisor of leading pharmaceutical and biotech
companies across a wide range of therapeutic areas in all major healthcare markets
across the globe.
Dr. Dupuy received her Ph.D. and M.Phil. in Molecular Biophysics and Biochemistry from
Yale University and a B.A. in Physics with honors from Wellesley College where she was
a Goldwater Scholar and a Schiff Fellow.
She is the author and coauthor of several scientific publications and has research
experience in theoretical and experimental physics, biophysics, cell biology, cancer
biology, genomics, proteomics, bioinformatics and biochemistry.
![UNITED STATES DISTRICT COURT NORTHERN … · 398, 400 ] Before the Court are two motions filed by Defendant Genentech, Inc. (“Genentech”). The ... nia action against Genentech](https://img.pdfslide.us/doc/110x75/5bb0214f09d3f2b25c8dce07/united-states-district-court-northern-398-400-before-the-court-are-two-motions.jpg)
